Iterum Therapeutics Plc (ITRM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

BLOCK 2 FLOOR 3, HARCOURT CENTRE DUBLIN, IRELAND 2

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications.

Data as of 2021-07-25 17:35:31 -0400
Market Cap202.427 Million Shares Outstanding179.139 Million Avg 30-day Volume19.981 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.01 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.72696 52-week High/Low3.0 / 0.451 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -4.1212
Data provided by IEX Cloud
View SEC Filings from ITRM instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 50 20 150.0% 15 (0.88%) 8 (0.46%) 87.5%
13F shares: 7.975 Million 6.984 Million 14.2% 4.385 Million 4.026 Million 8.91%
% Ownership 4.5192 14.2292 -68.24% 2.4845 8.2026 -69.71%
New Positions: 34 12 183.33% 8 3 166.67%
Increased Positions 6 1 500.0% 2 1 100.0%
Closed Positions 4 5 -20.0% 1 2 -50.0%
Reduced Positions 1 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ITRM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ITRM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUNNE MICHAEL W.

  • Director
336,355 2021-07-25 5

FISHMAN COREY N. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
5,280,000 2021-06-23 3

MATTHEWS JUDITH M. CHIEF FINANCIAL OFFICER

  • Officer
1,936,000 2021-06-23 4

AHRENS BRENTON KARL

  • Director
64,706 2021-06-23 1

HUNT RONALD

  • Director
36,798 2021-06-23 1

CHIN MARK

  • Director
36,798 2021-06-23 1

KELLY DAVID GEORGE

  • Director
64,706 2021-06-23 1

HECHT BETH

  • Director
36,798 2021-06-23 2

DENNER ALEXANDER J

SARISSA CAPITAL MANAGEMENT LP

SARISSA CAPITAL OFFSHORE MASTER FUND LP

SARISSA CAPITAL CATAPULT FUND LLC

SARISSA CAPITAL HAWKEYE FUND LP

SARISSA CAPITAL MASTER FUND II LP

  • 10% Owner
No longer subject to file 2021-02-11 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2021-02-04 2

HERON PATRICK J

  • Director
1,547,322 2020-07-01 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

HEALY JAMES

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2020-06-01 0

HEALY JAMES

  • Director
  • 10% Owner
0 2020-01-21 0

CANAAN X L.P.

CANAAN PARTNERS X LLC

  • Director
  • 10% Owner
0 2020-01-21 0

MALIK SHAHZAD

  • Director
0 2020-01-21 0

FRAZIER HEALTHCARE VII, L.P.

FRAZIER HEALTHCARE VII-A, L.P.

FHM VII, L.P.

FHM VII, L.L.C.

  • 10% Owner
0 2020-01-21 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

POWELL MICHAEL

  • 10% Owner
0 2020-01-21 0

EDICK PAUL R

  • Director
31,390 2019-05-24 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

POWELL MICHAEL

SOFINNOVA MANAGEMENT IX, L.L.C.

MEHRA ANAND

  • 10% Owner
1,726,514 2018-05-30 0

HERON PATRICK J

FRAZIER HEALTHCARE VII, L.P.

FRAZIER HEALTHCARE VII-A, L.P.

FHM VII, L.L.C.

FHM VII, L.P.

  • Director
  • 10% Owner
1,538,316 2018-05-30 0

LATHI VIJAY K

RATCLIFFE LIAM

  • 10% Owner
1,456,303 2018-05-30 0

SCHAFFNIT JEFFREY R. CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-05-24 0

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURES III, L.P.

LATHI VIJAY K

RATCLIFFE LIAM

  • 10% Owner
0 2018-05-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DUNNE MICHAEL W. - Director

2021-07-27 21:30:14 -0400 2021-07-25 A 80,000 a 336,355 direct

MATTHEWS JUDITH M. - Officer CHIEF FINANCIAL OFFICER

2021-06-25 16:05:10 -0400 2021-06-23 A 1,936,000 a 1,936,000 direct

FISHMAN COREY N. - Director - Officer CHIEF EXECUTIVE OFFICER

2021-06-25 16:06:02 -0400 2021-06-23 A 5,280,000 a 5,280,000 direct

HUNT RONALD - Director

2021-06-25 16:05:32 -0400 2021-06-23 A 36,798 a 36,798 direct

CHIN MARK - Director

2021-06-25 16:06:36 -0400 2021-06-23 A 36,798 a 36,798 direct

AHRENS BRENTON KARL - Director

2021-06-25 16:05:55 -0400 2021-06-23 A 64,706 a 64,706 direct

HECHT BETH - Director

2021-06-25 16:05:21 -0400 2021-06-23 A 36,798 a 36,798 direct

KELLY DAVID GEORGE - Director

2021-06-25 16:06:07 -0400 2021-06-23 A 64,706 a 64,706 direct

DUNNE MICHAEL W. - Director

2021-06-25 16:05:44 -0400 2021-06-23 A 36,798 a 36,798 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 16:45:03 UTC -4.2153 4.2953 3800000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 16:15:02 UTC -4.2153 4.2953 3900000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 15:45:03 UTC -4.2153 4.2953 3900000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 15:15:03 UTC -4.2153 4.2953 3900000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 14:45:02 UTC -4.2654 4.3454 4100000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 14:15:03 UTC -4.2654 4.3454 4100000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 13:45:02 UTC -4.2654 4.3454 4100000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 13:15:03 UTC -4.2654 4.3454 4000000
ITERUM THERAPEUTICS PLC ITRM 2021-07-28 12:45:03 UTC -4.2654 4.3454 4000000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 22:15:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 21:45:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 21:15:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 20:45:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 20:15:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 19:45:02 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 19:15:02 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 18:45:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 18:15:02 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 17:45:03 UTC -4.2654 4.3454 3200000
ITERUM THERAPEUTICS PLC ITRM 2021-07-27 17:15:03 UTC -4.2654 4.3454 3200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments